Marijuana may be a “gateway,” but not in the stigmatized way it’s been portrayed by prohibitionists as a stepping stone to other drugs. Rather, a growing body of scientific literature signals cannabis is a “gateway to women’s orgasm” that could hold significant therapeutic potential in the treatment of female orgasmic disorder/difficulty (FOD), a new research paper says.
For the analysis, published in the journal Current Sexual Health Reports last week, clinical sexologist Suzanne Mulvehill discussed how, even though FOD affects an estimated 72 percent of premenopausal women, there are currently no drugs approved by the Food and Drug Administration (FDA) to treat the condition. And cannabis represents a novel therapy that could fill that treatment gap.
“Psychiatrists have traditionally been trained to define legitimate prescribing primarily through formally regulated pharmaceutical pathways, even while routinely prescribing medications off-label. For FOD, cannabis falls outside this conventional framework,” the report says. “Recognizing its therapeutic value therefore asks psychiatry to broaden its understanding of what constitutes medicine and evidence-based care, particularly for conditions that lack effective conventional pharmacologic options.”
“Five decades of convergent evidence…demonstrate a consistent association between cannabis use and enhanced orgasmic function.”
Mulvehill emphasized that incorporating cannabis into sexual medicine “will require
Read full article on Marijuana Moment
